{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:39:00Z","timestamp":1793263140417,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273855"],"award-info":[{"award-number":["82273855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2225002"],"award-info":[{"award-number":["T2225002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474143"],"award-info":[{"award-number":["82474143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA0530301"],"award-info":[{"award-number":["XDA0530301"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1260301"],"award-info":[{"award-number":["XDB1260301"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0830000"],"award-info":[{"award-number":["XDB0830000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Chinese Academy of Sciences Youth Innovation Promotion Association","doi-asserted-by":"publisher","award":["2023296"],"award-info":[{"award-number":["2023296"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2305904"],"award-info":[{"award-number":["2023YFC2305904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400504"],"award-info":[{"award-number":["2022YFC3400504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109665","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:11:39Z","timestamp":1791558699000},"page":"109665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Laminarin suppresses PD-L1 translation by targeting YTHDF1 to exert antitumor immunity in triple-negative breast cancer"],"prefix":"10.1016","volume":"233","author":[{"given":"Fangning","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianuo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2026.109665_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: A Review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2026.109665_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.phrs.2026.109665_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.62347\/PNGT6996","article-title":"J. Zhao, Immune evasion and resistance in breast cancer","volume":"15","author":"Ababneh","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.109665_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2026.109665_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","article-title":"Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design","volume":"9","author":"Kassam","year":"2009","journal-title":"Clin. Breast Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib8","first-page":"75","article-title":"Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance","volume":"1","author":"Bai","year":"2021","journal-title":"J. Natl. Cancer Cent."},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10549-017-4537-5","article-title":"Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study","volume":"167","author":"Dirix","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"21","key":"10.1016\/j.phrs.2026.109665_bib10","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study","volume":"34","author":"Nanda","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2026.109665_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41591-025-03698-4","article-title":"PD-L1 and the dawn of modern cancer immunotherapy","volume":"31","author":"Chen","year":"2025","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.109665_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2026.109665_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-Negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-025-01734-x","article-title":"Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000-2025)","volume":"18","author":"Huang","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2026.109665_bib16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41571-018-0086-z","article-title":"Economic sustainability of immune-checkpoint inhibitors: the looming threat","volume":"15","author":"Verma","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2026.109665_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s43018-024-00730-3","article-title":"Clinical and translational attributes of immune-related adverse events","volume":"5","author":"Suijkerbuijk","year":"2024","journal-title":"Nat. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2026.109665_bib18","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1021\/acs.jmedchem.3c02143","article-title":"Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1\/PD-L1 Pathway","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2026.109665_bib19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1039\/c3fo60295h","article-title":"Origin and concept of medicine food homology and its application in modern functional foods","volume":"4","author":"Hou","year":"2013","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.phrs.2026.109665_bib20","article-title":"Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","volume":"5","author":"Wang","year":"2024","journal-title":"Cell. Rep. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.109665_bib21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib22","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2026.109665_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123302","article-title":"Preparation and structural characterization of acid-extracted polysaccharide from Grifola frondosa and antitumor activity on S180 tumor-bearing mice","volume":"234","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2026.109665_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121831","article-title":"An arabinose-rich heteropolysaccharide isolated from Belamcanda chinensis (L.) DC treats liver cancer by targeting FAK and activating CD40","volume":"331","author":"Zhao","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2026.109665_bib25","article-title":"Immunomodulatory and antivirus activities of bioactive polysaccharides and structure-function relationship","volume":"27","author":"Guo","year":"2022","journal-title":"Bioact. Carbohydr. Diet. Fibre"},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib26","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41467-023-37229-x","article-title":"Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2026.109665_bib27","first-page":"277","article-title":"Laminarin from Seaweed (Laminaria japonica) Inhibits Hepatocellular Carcinoma Through Upregulating Senescence Marker Protein-30","volume":"35","author":"Tian","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"issue":"6","key":"10.1016\/j.phrs.2026.109665_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-022-01558-0","article-title":"Targeting the RNA m6A modification for cancer immunotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2026.109665_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N6-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell. Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.109665_bib31","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"7743","key":"10.1016\/j.phrs.2026.109665_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41420-023-01321-4","article-title":"The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell. Death Discov."},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","article-title":"Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"issue":"1-2","key":"10.1016\/j.phrs.2026.109665_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","article-title":"N6-methyladenosine regulator YTHDF1 represses the CD8\u2009+\u2009T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A\/PD-L1 manner","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.phrs.2026.109665_bib37","article-title":"Identifying compound-protein interactions with knowledge graph embedding of perturbation transcriptomics","volume":"4","author":"Ni","year":"2024","journal-title":"Cell. Genom."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib38","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1038\/s41467-022-32205-3","article-title":"Connecting omics signatures and revealing biological mechanisms with iLINCS","volume":"13","author":"Pilarczyk","year":"2022","journal-title":"Nat. Commun."},{"issue":"W1","key":"10.1016\/j.phrs.2026.109665_bib39","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"A. Ma'ayan, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.phrs.2026.109665_bib40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/acsptsci.2c00008","article-title":"Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N6-Methyladenosine-Modified RNAs","volume":"5","author":"Micaelli","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"10265","key":"10.1016\/j.phrs.2026.109665_bib41","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"issue":"127","key":"10.1016\/j.phrs.2026.109665_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"41","key":"10.1016\/j.phrs.2026.109665_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202509316","article-title":"Identification of a Selective YTHDF1 Inhibitor Targeting the m6A Recognition Domain for Breast Cancer","volume":"64","author":"Wu","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.phrs.2026.109665_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.phrs.2026.109665_bib45","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/1078-0432.CCR-22-1110","article-title":"FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer","volume":"28","author":"Shah","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","article-title":"Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer","volume":"42","author":"Shiao","year":"2024","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.phrs.2026.109665_bib47","article-title":"Enhancing anti-tumor immunity and reducing toxicity: A medicine and food homology formula for ICB therapy","volume":"1","author":"Wang","year":"2025","journal-title":"Cell. Biomater."},{"key":"10.1016\/j.phrs.2026.109665_bib48","article-title":"Advances and prospects of targeting research for polysaccharide based drugs: A review","volume":"9","author":"Shui","year":"2025","journal-title":"Carbohydr. Polym. Technol. Appl."},{"issue":"801","key":"10.1016\/j.phrs.2026.109665_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn6921","article-title":"Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors","volume":"17","author":"Yang","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.phrs.2026.109665_bib50","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41592-025-02781-5","article-title":"High-throughput profiling of chemical-induced gene expression across 93,644 perturbations","volume":"22","author":"Xiang","year":"2025","journal-title":"Nat. Methods"},{"issue":"12","key":"10.1016\/j.phrs.2026.109665_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"5795","key":"10.1016\/j.phrs.2026.109665_bib52","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"issue":"W1","key":"10.1016\/j.phrs.2026.109665_bib53","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.109665_bib55","article-title":"The Gene Ontology knowledgebase in 2023","volume":"224","author":"Aleksander","year":"2023","journal-title":"Genetics"},{"issue":"D1","key":"10.1016\/j.phrs.2026.109665_bib56","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.phrs.2026.109665_bib57","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2026.109665_bib58","article-title":"Impact of molecular weight and gastrointestinal digestion on the immunomodulatory effects of Lycium barbarum polysaccharides","volume":"274","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"Pt 1","key":"10.1016\/j.phrs.2026.109665_bib59","article-title":"Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction","volume":"261","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.phrs.2026.109665_bib60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.cell.2014.10.057","article-title":"Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi","volume":"159","author":"Deng","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2026.109665_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.phrs.2026.109665_bib62","doi-asserted-by":"crossref","first-page":"45235","DOI":"10.1038\/srep45235","article-title":"BCIP: a gene-centered platform for identifying potential regulatory genes in breast cancer","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.phrs.2026.109665_bib63","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.phrs.2026.109665_bib64","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182601580X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182601580X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:29:17Z","timestamp":1793262557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182601580X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":64,"alternative-id":["S104366182601580X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109665","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laminarin suppresses PD-L1 translation by targeting YTHDF1 to exert antitumor immunity in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109665"}}